Ignazia Tusa

7PUBLICATIONS
24CO-AUTHORS
Clinical pharmacology and therapeuticsPredictive and prognostic markersEnvironmental epidemiologyFree radical chemistryAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 13, 2025
Dual-Specificity Protein Phosphatases Targeting Extracellular Signal-Regulated Kinases: Friends or Foes in the Biology of Cancer?

Alessandro Tubita, Dimitri Papini, Ignazia Tusa

|Feb 25, 2025
The MEK5/ERK5 pathway promotes the activation of the Hedgehog/GLI signaling in melanoma cells.

Ignazia Tusa, Sinforosa Gagliardi, Alessio Menconi

|Jun 30, 2023
Sphingosine 1-phosphate elicits a ROS-mediated proinflammatory response in human endometrial stromal cells via ERK5 activation.

Isabelle Seidita, Ignazia Tusa, Matteo Prisinzano

|May 16, 2023
Pathophysiological Impact of the MEK5/ERK5 Pathway in Oxidative Stress.

Ignazia Tusa, Alessio Menconi, Alessandro Tubita

|Sep 27, 2022
Anti-β4 integrin autoantibodies in patients with mucous membrane pemphigoid: A retrospective analysis from a tertiary centre in Italy.

Roberto Maglie, Carolina Vieira De Almeida, Maria Efenesia Baffa

|May 28, 2022
Targeting MAPK in Cancer 2.0.

Elisabetta Rovida, Ignazia Tusa

Pageof 2